SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001622627-24-000043
Filing Date
2024-07-11
Accepted
2024-07-11 17:52:18
Documents
2
Group Members
AHARON GILROSALIND ADVISORS, INC.ROSALIND MASTER FUND L.P.SALAMON STEVEN A J

Document Format Files

Seq Description Document Type Size
1 trvi_13ga_02_jul24.htm SC 13G/A 87122
2 trvi_exa_apr24.htm EX-99.A BD-DIR-RESOL 2256
  Complete submission text file 0001622627-24-000043.txt   91102
Mailing Address 195 CHURCH STREET 14TH FLOOR NEW HAVEN CT 06510
Business Address 195 CHURCH STREET 14TH FLOOR NEW HAVEN CT 06510 203-304-2499
Trevi Therapeutics, Inc. (Subject) CIK: 0001563880 (see all company filings)

IRS No.: 450834299 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91005 | Film No.: 241112842
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 15 WELLESLEY STREET WEST SUITE 326 TORONTO A6 M4Y 0G7
Business Address 25 ADMIRAL ROAD TORONTO A6 M5R 2L4 4168887606
Rosalind Advisors, Inc. (Filed by) CIK: 0001622627 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1130
Type: SC 13G/A